UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: Renitec-10mg-Tablet-SE-AJ-MPD-BBDL

Renitec 10 mg tablett

MPID: SE-100001253-00010840
EURDID: 1211

Full name: Renitec 10 mg tablett

- Invented Name Part: Renitec

- Strength part: 10 mg

- Pharmaceutical dose form part: tablett

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: tablet

Legal status of supply: Medicinal product subject to medical prescription

Domain: human use

Resource status: Current

Product classification:

  • 100000095104 enalapril

Marketing Authorisation 1 of 1

Authorisation number: 10840

Region: Kingdom of Sweden

Marketing authorisation holder: Organon N.V.

Identifier:

  • LOC-100005843

Status: Valid (1988-09-16)

Package 1 of 1

PCID:

Description:
Blister, 98 tabletter

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 98 tablet

Package: 1 Box (Cardboard)

Containing:

Package: 14 Blister (Aluminium) (PolyAmide) (PolyVinyl Chloride)

Containing: 7 tablet

Manufactured Item

Dose form: tablet

Unit of presentation: tablet

Ingredient

Role: Active

Substance: enalapril maleate

Presentation strength: 10 milligram(s) / 1 tablet

Reference strength:
enalapril 7.64 milligram(s) / 1 tablet

Administrable Product (1 of 1)

Dose form: tablet

Unit of presentation:

Route of administration:

  • Oral use

Ingredients:

Ingredient

Role: Active

Substance: enalapril maleate

Presentation strength: 10 milligram(s) / 1 tablet

Reference strength:
enalapril 7.64 milligram(s) / 1 tablet